http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020063939-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1bedf26ed145fcc46cdd7f7c6b76653
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14
filingDate 2019-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b647d18bc049b8fff1764ee45c6b149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3bbda986f39fe5562a106ddf7ec3b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f86c11ffe6bf1d09d2bbf0faf8d91c47
publicationDate 2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020063939-A1
titleOfInvention Crystal form of upadacitinib and preparation method and use thereof
abstract The present invention relates to a new crystal form of upadacitinib, and a preparation method, a pharmaceutical composition containing the crystal form, and the use of the crystal form in the preparation of a JAK inhibitor and medicine for treating rheumatoid arthritis. The crystal form of the upadacitinib provided by the present invention has one or more improved properties than in the prior art, and is of great value to the optimization and development of medicine in the future.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11572365-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022007629-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021244323-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114206877-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020224633-A1
priorityDate 2018-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108368121-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465873181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164055894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID405945350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58557659
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422195915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146481400
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420320352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138335

Total number of triples: 44.